enGene Holdings, Inc. (ENGN)
7.33
+0.09
(+1.24%)
USD |
NASDAQ |
Apr 07, 16:00
8.01
+0.68
(+9.28%)
After-Hours: 07:04
enGene Holdings Total Assets (Quarterly) : 337.11M for Jan. 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 42.07M |
| Oncolytics Biotech, Inc. | 7.582M |
| Aurinia Pharmaceuticals, Inc. | 770.59M |
| Edesa Biotech, Inc. | 14.71M |
| Lexaria Bioscience Corp. | 6.051M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 55.57M |
| Shareholders Equity (Quarterly) | 281.55M |
| Debt to Equity Ratio | 0.1189 |
| Current Ratio | 11.75 |
| Net Debt Paydown Yield | -0.26% |